One benefit of jailbreaking - https://kindlemodding.org/jailbreaking/post-jailbreak/disabl...
HN user
kleinishere
Thoughts and posts are my own.
https://github.com/can1357/oh-my-pi
Pi+some additions here. Have not used it enough to have a strong opinion, however, I’ve seen it mentioned here.
Probably dependent on age of kids. For the 4yo-6yo demographic with no access to an iPhone or screen device, the analog phone is a blast. And family/friends, especially those living elsewhere, are having fun with it. Admittedly, we’re a month in but I’d be surprised if interest zeroed any time soon.
Run your own Asterisk server with special #0 that the kids can dial to listen to children’s podcasts, etc., it can be very entertaining.
Also stuck on Lightroom for this purpose. Have been looking for any analog/film perspectives on this update from Photrio and Reddit but nothing yet. Curious if this could potentially replace Negative Lab Pro (despite generally being quite good) in my workflow and take me out of Lightroom.
Thanks for linking this. What is the monthly spend? And how long ago did you do it? Has it grown/stayed the same/or decreased in its use?!
2017 EPA Award as well :
https://www.epa.gov/greenchemistry/green-chemistry-challenge...
This particular episode.
This kind of daily goal setting reminds me a lot of this podcast, if of interest. https://podcasts.apple.com/us/podcast/invest-like-the-best-w...
Any chance you’re doing this for film photography? I also use a plugin (Negative Lab Pro) for negative inversion of film scans that keeps me stuck on Lightroom Classic. It would be great to get a pipeline beyond Classic but with the ability to jump back and re-edit. Curious if you have more details on what you do/don’t connect into Immich from Lightroom.
Congrats on the innovative product and sticking with development!
How has the translation quality changed / improved since this Show HN a couple years back? https://news.ycombinator.com/item?id=39177467
For languages not using the Roman alphabet, is it required that the user know the characters already? After registering but before starting a trial, I wasn’t clear on this.
Some comparison of who should choose this over Duolingo and why (ie features) could be useful.
This makes a ton of sense - thank you for taking the time to write it out like that. Crystal clear. It’s somewhat different than what I’m solving for and that’s reassuring to see!
Happy Journelly user here! Finally a great place to store notes/links on my iPhone in a simple but powerful app for rediscovery. That I can bring to my windows / Linux / Mac eMacs.
I’ve looked into a log/journal date tree approach with my various activities across the day (meeting notes, independent work notes, etc) under the date. But then I prefer being able to look through headings that anchor on context first, then dates second (/eventually).
Does your daily log link to other parts of one org file, or other org files?
I’ve asked LLMs their opinions. But curious for yours!
Also thinking about trying denote. The filenames begin with dates, then use tags/keywords to keep the thread on recurring topics.
just encountered these in a local public library a week ago. toddlers loved them.
Encountered these miniature wood marble runs in Switzerland. Still on my “wish list.” Sounds like you may enjoy them, too.
Link to blog post? Didn’t see it on quick look at your site.
Feature request - a way to filter by age / difficulty from the home page. I see it on individual pages but didn’t quickly see the age listed as a tag. This is a point of friction on most coloring page sites. Congrats on this. I have bookmarked it. Thank you
For others who stumble upon this, another good free site without too many ads:
What stack? Are you considering a TUI overlay to make it remarkably efficient?
Didn’t realize this was available.
Similarly published by OpenAI: https://status.openai.com/
30 day comparisons as of writing:
99.61% for Claude.ai 99.22% for ChatGPT
99.92% for Claude APIs 99.25% for OpenAI APIs
Obviously not apples to apples and somewhat up to discretion of what triggers an impact. We’re clearly not at 99.99% yet.
Came here to find this. MANY upvotes.
I used Doom for a couple months.
Then started considering a vanilla eMacs. I started taking notes on packages I found highly recommended and interesting.
Then I found this. And the author has done all that work and then made it into a “let me walk through a config” including a lot of the most recommended packages and sensible configs.
Gives you the lesson of building a config, knowing what’s in your config, and then being fluent in changing it.
He also has more notes on his blog about the packages + more : https://www.jamescherti.com/essential-emacs-packages/
And I now feel comfortable making changes myself.
Phenomenal. Thank you.
For the many posters recommending BPA free paper - does anyone have suggestions / a link for a reliable seller?
I looked on Amazon after another receipt printer post on HN but couldn’t find anything that provided confidence in the BPA characterization. ULINE is quantities are absurd for personal use. Imagine their most be a decent alternative but never see any named.
Xenodium is doing amazing things for emacs. If you enjoy this or are generally emacs interested, I’d check out his blog @ https://xenodium.com/
I also purchased my first iOS app upon recommendation from other emacs users - the author’s app, Journelly. A simple portable place to save down links or notes and export out as org files (as one option; apparently markdown is on the way). https://xenodium.com/journelly-for-ios
No affiliation to Xenodium. I’ve just been diving into emacs this year and love seeing his contributions.
Potentially inhibiting IL-6 or reducing Lp(a). We'll get an early glimpse from some robust Phase 3's next year. These have been in the works for several years with tens of thousands of patients enrolled - it'll be an exciting set of readouts.
Novo Nordisk purchased Corvidia Therapeutics in 2020 [1] for their IL-6 antibody and will read out the first of three Phase 3's in 2026 [2]. Their programs, however, are focused on individuals with higher risk factors like chronic kidney disease (2026 topline), a couple kinds of heart failure (2027), and a prior myocardial infarction (heart attack; 2027). These trials notably are on top of "standard of care" existing therapies, so they're looking for additional benefit beyond what is commonly sought, like LDL reduction (highlighted in other comments).
Novartis recently announced an intended acquisition of Tourmaline Bio for their IL-6 antibody [3]. So attention to the biological target is heating up.
Another target mentioned in the comments is Lp(a). Genetic studies suggest a heightened risk of cardiovascular disease. Therapeutics aimed at reducing Lp(a) levels are being explored separate from IL-6 for a similar end goal of avoiding cardiovascular events (i.e. heart attacks, death).
Novartis will read out a Phase 3 of an Lp(a) reducing therapeutic in the first half of 2026 [4]. Amgen will likely read out theirs likely sometime thereafter [5]. These have been a long time coming: Amgen in-licensed their asset from Arrowhead in 2016 [6], Novartis in-licensed their asset from Ionis/Akcea in 2017 [7].
If any of these work, there's a chance that they'd be explored in patients with less pronounced risk than the original studies in these Phase 3's. Amgen has already announced an intent to explore their Lp(a) drug in a Phase 3 with participants with elevated Lp(a) at "high risk" for a first cardiovascular event in 2H25/1H26.
[1] https://ml-eu.globenewswire.com/Resource/Download/e7e162e5-a... [2] Page 113 - https://cdn.ipaper.io/iPaper/Files/ffd0326c-1fa6-41e5-a82d-0... Page 225 - https://investor.novonordisk.com/q2presentation2025/?page=22... [3] https://ir.tourmalinebio.com/news-releases/news-release-deta... [4] https://ir.ionis.com/static-files/66c5e90a-3651-480d-a596-1c..., https://clinicaltrials.gov/study/NCT04023552 [5] https://clinicaltrials.gov/study/NCT05581303?rank=1, Page 15 - https://investors.amgen.com/static-files/27fcb898-9cee-48db-... [6] https://www.amgen.com/newsroom/press-releases/2016/09/amgen-... [7] https://ir.ionis.com/news-releases/news-release-details/ioni...
Have you stuck with Doom/Space and evil key bindings or been pulled over to a more vanilla setup?
Correct. And confirmed by Kodak on their Facebook page. The “going concern” disclosure is an accounting requirement. However, the company claims to have line of sight toward addressing it.
https://www.facebook.com/share/p/19UdGkBYwr/?mibextid=wwXIfr
Also discussed on Reddit.
This is great - thank you! Hadn't seen the blog post or the MOOC. Appreciate the resources.
What packages and workflow specifically do you use? I haven’t come across many gentle introductions so looking for clues on what’s a reasonable first step that’s well maintained with good docs.
What specific features / functions are most compelling for lists? Of course moving a tree around with different header levels. But anything specifically great with lists?
Are there any keywords that help with identifying the most clean/neutral paper? Went down the rabbit hole briefly and had a tough time feeling confident in what was credibly Bpa free (at least on Amazon).